Design, synthesis and evaluation of novel levoglucosenone derivatives as promising anticancer agents
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 30 (14) , 127247
Abstract
No abstract availableKeywords
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica
This publication has 25 references indexed in Scilit:
- Targeting p53 by small molecules in hematological malignanciesJournal of Hematology & Oncology, 2013
- Recent developments in the field of oxa-Michael reactionsChemical Society Reviews, 2011
- A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast CancerCancer Cell, 2011
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core DomainCancer Cell, 2009
- Design, Synthesis, and Biological Evaluation of Levoglucosenone‐Derived Ras Activation InhibitorsChemMedChem, 2009
- p53—A Natural Cancer Killer: Structural Insights and Therapeutic ConceptsAngewandte Chemie International Edition, 2006
- A new solvent system for efficient synthesis of 1,2,3-triazolesTetrahedron Letters, 2006
- Copper(I)-Catalyzed Synthesis of Azoles. DFT Study Predicts Unprecedented Reactivity and IntermediatesJournal of the American Chemical Society, 2004
- Synthesis and thermal chemistry of isolevoglucosenoneCarbohydrate Research, 1986
- Some reactions of levoglucosenoneCarbohydrate Research, 1979